Skip to main content
. 2021 Nov 29;13(23):6011. doi: 10.3390/cancers13236011
AJCC American Joint Committee on Cancer
AP-1 Activator protein-1
BDNF Brain-derived neurotrophic factor
CI Confidence interval
cN Clinical nodal
CT Computed tomography
DNA Deoxyribonucleic acid
DOI Depth of invasion
EGFR Epidermal growth factor receptors
EMT Epithelial to mesenchymal transition
ENE Extracapsular nodal extension
ERK Extracellular-regulated protein kinase
FDA Food and Drug Administration
FGFR Fibroblast growth factor receptor
GALR Galanin receptor
GDNF Glial cell-derived neurotrophic factor
GFAP Glial fibrillary acidic protein
GFRalpha1 GDNF family receptor-alpha 1
HPV Human papilloma virus
HR Hazard ratio
IMRT Intensity-modulated radiation therapy
LOH Loss of heterozygosity
M Metastasis
MAPK Mitogen-activated protein kinase
MMP Matrix metalloproteinase
MR Magnetic resonance
mRNA Messenger ribonucleic acid
NCAM Neural cell adhesion molecule
NFATC Nuclear factor of activated T cells
NGF Nerve growth factor
OR Odds ratio
p75NTR p75 neurotrophin receptors
PD-L1 Programed cell death -ligand 1
pN Pathological nodal
PNI Perineural invasion
RET REarranged during Transfection
SCC Squamous cell carcinoma
shRNA Short hairpin ribonucleic acid
T Tumor
TNF Tumor necrosis factor
TrkA Tropomyosin receptor kinase A
TrkB Tropomyosin receptor kinase B